This post was authored by Greg Bendis, Founder and CEO of Reviticell
The promise of regenerative medicine is leveraging your body’s remarkable ability to repair and heal itself.
In the practice of regenerative medicine, doctors can prepare your own blood for orthopedic treatments, wound care and other restorative therapies. Your own body fat can be prepared in order to restore and reconstruct tissue systems which may have become depleted due to age, damage from trauma or birth defects. Body fat can also be prepared to isolated adult stem cells which have the potential to cure or reverse the course of a variety of diseases.
According to The Alliance for Regenerative Medicine, “Currently, the vast majority of treatments for chronic and/or life-threatening diseases are palliative. Very few therapies in use today are capable of curing or significantly changing the course of a disease. Regenerative Medicine, however, represents a new paradigm in human health, with the potential to resolve unmet medical needs by addressing the underlying cause of disease. This rapidly evolving, interdisciplinary field in healthcare is transforming the practice of medicine, medical innovation and the production of medical devices and therapies.”
Doctors are now seeking the best means to unlock the power to heal that lies within their patient’s bodies and to leverage this ability in targeted therapies. It is important that doctors have the same confidence when using regenerative medicine treatments as they would with pharmaceutical treatments that have been manufactured in highly-regulated labs. Accordingly, what they desire is a standardized system that will allow them to safely and efficiently prepare regenerative medicine treatments with predictable and consistent outcomes.
The standardized system that is needed would include the precise configuration of the exact components and the protocol necessary to prepare a specific regenerative medical treatment for a particular patient need. The inherent efficiency of such a system holds the potential to reduce medical costs and the risk of medical errors as compared to the variety of means and methods currently used to prepare regenerative medicine treatments.
Although machine-based systems have been developed to improve upon ad-hoc methods, such systems are expensive, inflexible and quickly become obsolete. What is needed is a standardized system that can be configured for individualized therapeutic treatments and upgraded as technology advances.
The ideal system would be a cost-effective, easy-to-use, point-of-care, single-use medical device. Such a device could revolutionize the current practice of preparing blood and tissue for therapeutic purposes. In addition, it could greatly advance the science of preparing body fat to isolate adult stem cells.
A series of studies to do just that have recently been approved to take place at University of Florida College of Medicine in Jacksonville, Florida. “We believe through regenerative medicine, physicians may be able to isolate well-characterized cell subtypes and potentially begin to engineer predictable, efficacious and safe clinical therapies,” stated John Murray, MD.
The University of Florida study will isolate stem cells using a standardized point-of-care system developed by Reviticell Holdings and will collaborate with researchers and technicians from University of Rochester. Thanks to an agreement with University of Florida, not only does Dr. Murray lead the Regenerative Medicine program at UF Health Jacksonville, he also serves as Reviticell’s Chief Medical Officer.
Find the best in healthcare innovation. Join angelMD today.
Image Credit: Reviticell